We present a rare case of anagrelide-induced pericardial effusion that
is presented with tamponade physiology in a patient with essential
thrombocythemia. After cautiously weighing the risks and benefits of
further invasive interventions following an unsuccessful
pericardiocentesis, the decision was to stop anagrelide while managing
the pericardial effusion medically.